At-Home Therapy

Australian biopharma company MindBio Therapeutics Corp. has shared positive topline results from its completed take-home microdosing clinical trial on major depressive disorder.  The treatment provided to the 20 participants is MB22001, the company's microdose formulation of a self-titratable...

Silo Pharma’s (NASDAQ: SILO) novel ketamine-loaded implant targeting fibromyalgia and chronic pain conditions, SP-26, is reportedly advancing through analytical testing and preclinical trials toward determining drug release and stability following approval by state and federal authorities....

DEA’s Proposed Telehealth Rules For Prescribing Controlled Substances Ketamine is the only psychedelic that can be lawfully prescribed (off-label) to treat mental health indications. It has also presented positive outcomes for a variety of conditions by individuals who were able to access...

Is At-Home Ketamine Treatment Safe For Patients? A new clinical study of sublingual ketamine telehealth is adding data to the notion that at-home ketamine treatments can be safe and effective for moderate to severe cases of anxiety and depression.  The study was conducted by psychiatrists...